Dr. David Marcus, M.D

NPI: 1437287208
Total Payments
$2,068
2020 Payments
$21.74
Companies
12
Transactions
114

Payment Breakdown by Category

Food & Beverage$2,050 (99.2%)
Education$17.06 (0.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,050 109 99.2%
Education $17.06 5 0.8%

Top Paying Companies

Company Total Records Latest Year
Lundbeck LLC $471.60 32 $0 (2018)
Sunovion Pharmaceuticals Inc. $449.02 26 $0 (2020)
Otsuka America Pharmaceutical, Inc. $304.11 19 $0 (2019)
Merck Sharp & Dohme Corporation $207.88 9 $0 (2018)
Teva Pharmaceuticals USA, Inc. $147.81 4 $0 (2019)
Allergan Inc. $141.93 7 $0 (2019)
Shire North American Group Inc $139.24 7 $0 (2017)
Janssen Pharmaceuticals, Inc $89.08 4 $0 (2017)
Alkermes, Inc. $44.42 2 $0 (2017)
Takeda Pharmaceuticals U.S.A., Inc. $28.89 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2020 $21.74 1 Sunovion Pharmaceuticals Inc. ($21.74)
2019 $164.55 9 Allergan Inc. ($47.94)
2018 $760.46 42 Merck Sharp & Dohme Corporation ($161.04)
2017 $1,121 62 Lundbeck LLC ($348.02)

All Payment Transactions

114 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
01/28/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $21.74 General
Category: CNS
07/01/2019 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $26.21 General
Category: Central Nervous System
06/24/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.17 General
Category: PSYCHIATRY
06/17/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $15.02 General
Category: CNS
04/19/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.01 General
Category: NEUROSCIENCE
03/13/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $6.65 General
Category: CNS
02/21/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $16.43 General
Category: CNS
02/04/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $23.32 General
Category: PSYCHIATRY
02/04/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $6.81 General
Category: CNS
01/28/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.93 General
Category: NEUROSCIENCE
12/17/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $3.47 General
Category: CNS
12/11/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $21.97 General
Category: CNS
12/05/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.45 General
Category: NEUROSCIENCE
12/03/2018 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $10.79 General
Category: PSYCHIATRY
11/19/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.22 General
Category: NEUROSCIENCE
11/19/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $4.95 General
Category: Central Nervous System (CNS)
11/14/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $22.95 General
Category: CNS
11/10/2018 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $113.41 General
Category: Central Nervous System
11/07/2018 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $4.77 General
Category: PSYCHIATRY
11/05/2018 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $16.96 General
Category: NEUROSCIENCE
10/31/2018 Lundbeck LLC TRINTELLIX (Drug) Food and Beverage Cash or cash equivalent $20.46 General
Category: PSYCHIATRY
10/15/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.86 General
Category: NEUROSCIENCE
10/01/2018 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $20.52 General
Category: PSYCHIATRY
10/01/2018 Teva Pharmaceuticals USA, Inc. Education In-kind items and services $7.53 General
10/01/2018 Teva Pharmaceuticals USA, Inc. Education In-kind items and services $0.66 General

About Dr. David Marcus, M.D

Dr. David Marcus, M.D is a Psychiatry healthcare provider based in Wilmington, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437287208.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Marcus, M.D has received a total of $2,068 in payments from pharmaceutical and medical device companies, with $21.74 received in 2020. These payments were reported across 114 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,050).

Practice Information

  • Specialty Psychiatry
  • Location Wilmington, CA
  • Active Since 03/01/2007
  • Last Updated 11/25/2019
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1437287208

Products in Payments

  • LATUDA (Drug) $449.02
  • REXULTI (Drug) $272.85
  • ABILIFY MAINTENA (Drug) $265.23
  • TRINTELLIX (Drug) $237.63
  • BELSOMRA (Drug) $207.88
  • VRAYLAR (Drug) $141.93
  • AUSTEDO (Drug) $139.62
  • INVEGA SUSTENNA (Drug) $89.08
  • MYDAYIS (Drug) $73.45
  • VYVANSE (Drug) $65.79
  • Trintellix (Drug) $48.76
  • Aristada 441 mg (Drug) $44.42
  • NUEDEXTA (Drug) $23.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Wilmington